Letters
Too much medicine
Direct to consumer unproved screening tests turn a profit in Japan
BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4725 (Published 30 July 2013) Cite this as: BMJ 2013;347:f4725- Yasuharu Tokuda, internist1,
- Mitchell D Feldman, professor of medicine2
- 1University of Tsukuba, 3-2-7 Miya-machi, Mito, Ibaraki, Japan
- 2University of California, San Francisco, 1545 Divisadero, Suite 315, San Francisco, CA 94143-0320, USA
- yasuharu.tokuda{at}gmail.com
Japanese doctors and patients face much the same problem of too much medicine outlined by Glasziou and colleagues.1 The Japanese healthcare system is rightly lauded as a model of cost containment while achieving better outcomes on many key health indicators than the United States and other developed nations …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.